Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV001401854 | SCV001603688 | likely benign | 3-methylcrotonyl-CoA carboxylase 2 deficiency | 2024-01-02 | criteria provided, single submitter | clinical testing | |
Natera, |
RCV001279166 | SCV001466248 | uncertain significance | Methylcrotonyl-CoA carboxylase deficiency | 2020-08-29 | no assertion criteria provided | clinical testing | |
Prevention |
RCV003898263 | SCV004715828 | likely benign | MCCC2-related disorder | 2022-08-09 | no assertion criteria provided | clinical testing | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). |